Loading...

Sandoz Group AG

SDZNYPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$60.23
$0.34(0.57%)

Sandoz Group AG SDZNY Peers

See (SDZNY) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
SDZNY$60.23+0.57%26B-3015.50-$0.02+1.13%
MKGAF$137.00+1.84%59.6B18.00$7.61+1.87%
MKKGY$26.81+0.07%57.6B17.71$1.51+1.88%
TKPHF$29.50-8.19%46.4B65.56$0.45+4.80%
HLNCF$4.93+1.02%44.2B23.45$0.21+1.78%
IPSEY$33.00+1.79%43.7B26.61$1.24+0.82%
ESALY$61.51-2.11%17.6B20.54$3.00N/A
TEVJF$14.00+0.00%16.1B-12.17-$1.15N/A
SGIOY$8.57+0.23%14.6B12.79$0.67+1.86%
SGIOF$16.20+0.00%13.8B12.00$1.35+2.57%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

SDZNY vs MKGAF Comparison

SDZNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SDZNY stands at 26B. In comparison, MKGAF has a market cap of 59.6B. Regarding current trading prices, SDZNY is priced at $60.23, while MKGAF trades at $137.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SDZNY currently has a P/E ratio of -3015.50, whereas MKGAF's P/E ratio is 18.00. In terms of profitability, SDZNY's ROE is +0.00%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, SDZNY is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for SDZNY.

Stock Price Comparison

Loading...

Frequently Asked Questions

;